Tag: pharmaceutical industry

The suit also includes their affiliated group purchasing organizations (GPOs), accusing them of blocking patients from accessing cheaper alternatives and distorting drug markets for profit.

As Novo Nordisk rakes in billions, Sen. Bernie Sanders and public health advocates demand answers on why U.S. patients are charged sky-high prices for life-saving drugs like Ozempic while generics could sell for a fraction of the cost.

A Maine woman’s story highlights the impact of progressive action on drug prices.

President Biden and Sen. Bernie Sanders call out pharmaceutical companies for overcharging Americans, urging immediate reform.

The Federal Trade Commission intensifies its fight against pharmaceutical patent abuses, aiming to slash drug prices and increase access to generic medications.

Following Boehringer Ingelheim's lead, AstraZeneca pledges affordable respiratory care in the U.S., sparking calls for industry-wide reform.

This procedural dismissal effectively sidelines the pharmaceutical industry's concerted efforts to maintain control over drug pricing, marking a significant victory for proponents of healthcare reform.

Florida's groundbreaking move: importing affordable medication from Canada. Big Pharma's pushback and the FDA's historic approval — a turning point in U.S. healthcare?

A DeSmog review of hundreds of documents identifies eight arguments fielded by the industrial farming lobby to allay concerns over livestock drugs.

An analysis of the $6 billion in grants distributed by PhRMA and its member companies.